US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

RGNX

REGENXBIO (RGNX)

REGENXBIO Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:RGNX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/17	06 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RGNX	REGENXBIO Inc
2024/05/15	05 : 22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RGNX	REGENXBIO Inc
2024/05/10	20 : 05	PR Newswire (US)	REGENXBIO to Participate in Upcoming Investor Conferences	NASDAQ:RGNX	REGENXBIO Inc
2024/05/09	05 : 16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RGNX	REGENXBIO Inc
2024/05/09	05 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RGNX	REGENXBIO Inc
2024/05/09	05 : 05	PR Newswire (US)	REGENXBIO Reports First Quarter 2024 Financial Results and Recent Operational Highlights	NASDAQ:RGNX	REGENXBIO Inc
2024/05/01	20 : 05	PR Newswire (US)	REGENXBIO to Host Conference Call on May 8 to Discuss First Quarter 2024 Financial Results and Recent Operational Highlights	NASDAQ:RGNX	REGENXBIO Inc
2024/04/24	20 : 05	PR Newswire (US)	REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit	NASDAQ:RGNX	REGENXBIO Inc
2024/03/28	20 : 05	PR Newswire (US)	REGENXBIO Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time Gene Therapy for Wet AMD	NASDAQ:RGNX	REGENXBIO Inc
2024/03/28	05 : 05	PR Newswire (US)	REGENXBIO to Participate in Cantor Fitzgerald's Virtual DMD and Other Dystrophy Days	NASDAQ:RGNX	REGENXBIO Inc
2024/03/11	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RGNX	REGENXBIO Inc
2024/03/11	20 : 05	PR Newswire (US)	REGENXBIO to Participate in Upcoming Investor Conferences	NASDAQ:RGNX	REGENXBIO Inc
2024/03/08	20 : 09	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:RGNX	REGENXBIO Inc
2024/03/08	08 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RGNX	REGENXBIO Inc
2024/03/07	20 : 03	Edgar (US Regulatory)	Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses	NASDAQ:RGNX	REGENXBIO Inc
2024/03/07	13 : 20	PR Newswire (US)	REGENXBIO Announces Pricing of Upsized Public Offering of Common Stock and Pre-funded Warrants	NASDAQ:RGNX	REGENXBIO Inc
2024/03/07	06 : 23	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:RGNX	REGENXBIO Inc
2024/03/07	06 : 10	PR Newswire (US)	REGENXBIO Announces Proposed Public Offering of Common Stock	NASDAQ:RGNX	REGENXBIO Inc
2024/03/06	06 : 26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RGNX	REGENXBIO Inc
2024/03/05	21 : 05	PR Newswire (US)	REGENXBIO ANNOUNCES NEW POSITIVE INITIAL EFFICACY DATA FROM AFFINITY DUCHENNE® TRIAL	NASDAQ:RGNX	REGENXBIO Inc
2024/03/01	06 : 57	PR Newswire (US)	REGENXBIO to Host Webcast Event to Discuss New Interim Clinical Data from the Phase I/II AFFINITY DUCHENNE® Trial	NASDAQ:RGNX	REGENXBIO Inc
2024/02/28	06 : 54	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:RGNX	REGENXBIO Inc
2024/02/28	06 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RGNX	REGENXBIO Inc
2024/02/28	06 : 05	PR Newswire (US)	REGENXBIO Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights	NASDAQ:RGNX	REGENXBIO Inc
2024/02/21	21 : 05	PR Newswire (US)	REGENXBIO to Host Conference Call on February 27 to Discuss Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights	NASDAQ:RGNX	REGENXBIO Inc
2024/02/17	08 : 28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RGNX	REGENXBIO Inc
2024/02/08	01 : 40	PR Newswire (US)	REGENXBIO Announces Pivotal Trial of RGX-121 for the Treatment of MPS II Achieves Primary Endpoint	NASDAQ:RGNX	REGENXBIO Inc
2024/02/07	21 : 05	PR Newswire (US)	REGENXBIO Announces Completion of Enrollment in Cohort 2 and Additional Positive Interim Data in AFFINITY DUCHENNE® Trial	NASDAQ:RGNX	REGENXBIO Inc
2024/01/31	21 : 05	PR Newswire (US)	REGENXBIO Announces Presentations at the 20th Annual WORLDSymposium 2024	NASDAQ:RGNX	REGENXBIO Inc
2024/01/19	08 : 39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RGNX	REGENXBIO Inc

Showing the most relevant articles for your search:NASDAQ:RGNX

1 2 3 4 5 6 7 8 9 10 次へ >>

Deutsche Telekom (QX)

BNP Paribas (QX)

Verizon Communications

American Express

Financial Select Sector

Invesco QQQ Trust Series 1

US Dollar vs Yen

Gold vs US Dollar

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約